Motore di Ricerca in Medicina: Mediexplorer

Motore di Ricerca in Medicina: Mediexplorer

Medicina :: Database, Medical Search Engine, Motore di Ricerca in Medicina :: Mediexplorer.net,  Database Medico, Database in Medicina, FarmaExplorer :: Motore di Ricerca sui Farmaci, Farmacovigilanza :: FarmAlert, Database Farmaci :: Farmapedia, Correlazioni in Medicina :: MedFocus, Continuing Medical Education :: Medilearn, Top News in Medicina :: Mediline, Enciclopedia medica :: Medpedia, Centri di Cura :: Ospedali, Newsletter di Aggiornamento in Medicina, Medicine Newsletter, Aggiornamenti in Medicina, Newsletter Medicina, Newsletter Terapia medica
Aripiprazolo

Uno studio ha valutato l’efficacia a lungo termine di Aripiprazolo …
L’assunzione di Acidi grassi …

Assumere integratori a base di Acidi grassi Omega-3 potrebbe …
Benzodiazepine e rabdomiolisi

La rabdomiolisi è una sindrome clinica ad eziologia multipla …
Cetuximab

Cetuximab ( Erbitux ) in aggiunta al trattamento …
Ipotiroidismo

TSH sierico entro il range di riferimento come predittore di …
Artrite psoriasica

Otezla per il trattamento dei pazienti affetti da psoriasi e …
Spondilite anchilosante

Spondilite anchilosante: la terapia anti-TNF a lungo termine non …
Idrossiurea

Ricerca per Idrossiurea – Trovati 13. Il trattamento con …
Pemfigo

Ricerca per Pemfigo – Trovati 17 … del pemfigo giovanile e dell …
Bronchite acuta

Ricerca per Bronchite acuta – Trovati 10. Bronchite acuta …

Cardiology Updates by Xagena

Updates in Cardiology

Top News / Myocardial infarction: Heparin vs Bivalirudin

” Even if Heparin alone had produced statistically similar outcomes to Bivalirudin, it would have been a win for Heparin. A drug that costs less than a 1/400th of another that has similar efficacy and safety ought to be used preferentially “  Peter Berger and James Blankenship of Geisinger Health System, in Pennsylvania, USA

Myocardial infarction: Heparin rather than Bivalirudin after primary percutaneous coronary intervention can improve outcomes and save health budgets millions

A new study has compared outcomes for two drugs used to prevent blood clot formation during emergency myocardial infarction treatment. The study suggests that use of one of the drugs, Heparin, could …
Focus On: Diabetes mellitus & Heart failure
Sitagliptin therapy has shown no sign of increasing risk for all-cause hospitalization or death ( primary end point ), but the use of Sitagliptin was associated with greater risk of hospitalization for heart failure

Sitagliptin linked to increased risk of heart failure-related hospitalizations among patients with type 2 diabetes with pre-existing heart failure

The study objective was to evaluate the effects of Sitagliptin ( Januvia ), a dipeptidyl peptidase 4 inhibitor, in patients with type 2 diabetes ( T2D ) and heart failure ( HF ). There is uncertain …

News

Benefits of percutaneous MitraClip device for mitral regurgitation in high-surgical-risk patients: EVEREST II trial

The EVEREST II ( Endovascular Valve Edge-to-Edge REpair Study ) High-Risk registry and REALISM Continued Access Study High-Risk Arm are prospective registries of patients who received the MitraClip de …

Nonselective agents with greater inhibition of Cox-1 than Cox-2, such as Ibuprofen, were not associated with increased cardiovascular risk

Conclusive data about cardiovascular toxicity of nonsteroidal anti-inflammatory drugs ( NSAIDs ) are sparse. It has been hypothesized that regular NSAID use is associated with increased risk for cardi …

High-potency statin reduces mortality in survivors of an acute myocardial infarction

A study has determined all-cause mortality in patients with a first myocardial infarct who were treated with Simvastatin ( Zocor ) compared with high-potency statin and Simvastatin / Ezetimibe

Medicina: Aggiornamenti by Xagena

Medicina :: Xagena.net: Drugs

Xagena.net, Medicine, Newsletter :: Medicine, Medical News, Medical Search EngineNews :: Medicine, AZ Guide Medicine, Specialty :: Allergology, Specialty :: Andrology, Specialty :: Cardiology, Specialty :: Dermatology, Specialty :: Diabetology, Specialty :: Diagnostics,

Cardiologia Farmaci

Xagena.net Cardiologia. … Cardiologia Farmaci. Xagena …

Oncologia – Farmaci

Oncologia Farmaci …. L’utilizzo ottimale di farmaci citotossici …

Safinamide

The Committee for Medicinal Products for Human Use …

Inflectra

Hospira has announced the European Commission ( EC …

News

La stenosi aortica rappresenta la malattia valvolare cardiaca con …

Ischemia critica degli arti …

Ischemia critica degli arti: terapia farmacologica. Quando l …

Precedente

La renina è un enzima prodotto dai reni che … Leggi articolo …

Studio INVEST: la strategia …

Lo studio INVEST ( The … terapeutica a base di …

Ginecologia – Farmaci

Xagena.net Ginecologia. … Ginecologia Farmaci …

Possibilità di iperkaliemia …

Possibilità di iperkaliemia associando lo Spironolattone …